On the heels of Wednesday’s news that the U.S. House of Representatives introduced bipartisan legislation that would formally designate pharmacists as healthcare providers under Medicare Part B, the U.S. Senate has followed suit with a companion bill.
The NACDS-PAC supported a majority of winners in Tuesday's elections, comprising 86% in Senate races and 93% in House races, Steven Anderson, president and CEO of the National Association of Chain Drug Stores, said in a memo released Wednesday.
The Council for Responsible Nutrition on Monday praised the U.S. House of Representatives for its passage of the Designer Anabolic Steroid Control Act of 2014 (H.R. 4771), introduced by Reps. Joe Pitts, R-Pa., and Frank Pallone, D-N.J.
This week, 49 members of the U.S. House of Representatives urged Health and Human Services Secretary Kathleen Sebelius to adopt a one-year transition period for states to implement the July 2014 average manufacturer price-based federal upper limits.
In lead-up to a House Panel hearing on Thursday, the National Association of Chain Drug Stores submitted a statement expressing its support for the leadership and efforts of Congress and the Food and Drug Administration in taking common-sense approaches in safeguarding the process of delivering prescription medications to patients.
Bipartisan legislation that would designate pharmacists as healthcare providers under the Medicare program was introduced in the U.S. House of Representatives on Tuesday. The bill would amend The Social Security Act of 1935 to enable pharmacists to work to their full capability by providing underserved patients in the Medicare program with services not currently available to them.
As one of the most accessible healthcare providers in the community, pharmacists are an ideal resource for consumers on the risks of illegal Internet drug sellers. That was a key message that the National Association of Chain Drug Stores stressed in a statement submitted to a congressional panel.
U.S. House of Representatives Energy and Commerce Committee vice chair Marsha Blackburn, R-Tenn., and Rep. Tom Marino, R-Pa., have introduced legislation that would establish a work group to explore opportunities to reduce prescription drug abuse without compromising access to medications for patients who legitimately need them.
The National Association of Chain Drug Stores underscored its commitment to improving the quality and affordability of the nation’s healthcare system and expressed concern about potential consequences of restricted pharmacy networks with the Patient Protection and Affordable Care Act exchange plans.
The National Association of Chain Drug Stores has announced that in lead-up to a hearing of the Subcommittee on Health of the U.S. House of Representatives Committee on Energy and Commerce, it has submitted a statement emphasizing the important collaborative role that pharmacy plays in helping to ensure that prescription medications are used appropriately and that local communities are safe.
The National Community Pharmacists Association CEO Douglas Hoey testified Tuesday before the U.S. House of Representatives Energy and Commerce Subcommittee on Health’s hearing on “Reforming the Drug Compounding Regulatory Framework.”
The National Association of Chain Drug Stores made its voice heard before the U.S. House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations on the role of pharmacists in influenza vaccination, the retail pharmacy lobbying group said Wednesday.
Widespread reliance on telemedicine to electronically deliver health and pharmacy services to hard-to-reach patients in remote locations is getting closer to reality. And in a fast-evolving health care system struggling to improve access to health services at a lower overall cost, that’s a good thing.
Honoring the 100th anniversary of the vitamin, Rep. Frank Pallone, D-N.J., last week entered into the U.S. House of Representatives' Congressional Record remarks recognizing this special milestone, the Council for Responsible Nutrition announced.
In a statement issued on Monday, the National Association of Chain Drug Stores applauded the U.S. Senate for its passage of the “Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012,” also known as the “Safe Doses Act” (H.R. 4223 and S. 1002).
Written testimony submitted by the National Association of Chain Drug Stores underscored chain pharmacies’ commitment to patient safety as part of the next Prescription Drug User Fee Act reauthorization, and emphasized that community pharmacist-provided services help improve health outcomes without the introduction of unproven technologies.
The National Association of Chain Drug Stores on Thursday testified before the House of Representatives' Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade to emphasize retail pharmacy’s commitment to preserving patient safety and high-quality care.